CARISA
- 600 participants
- 2 sites in New Zealand
Combination Assessment of Ranolazine In Stable Angina. An open-label, long-term, safety study of Ranolazine SR for chronic stable angina pectoris at doses of 500mg, 750mg and 1000mg twice a day administered in combination with background anti-anginal therapy.